Dartmouth Researchers Engineer Drug Micro-factory to Attack Tumor
May 14, 2015 | NCCC
Dartmouth investigators, including professors Barjor Gimi and Karl Griswold, have engineered therapeutic cells inside nanoporous capsules to secrete antitumor molecules from within the tumor.
Food Dye, Near Infrared Light Can Aid in Breast Resection
May 12, 2015 | NCCC
Investigators at the Optics in Medicine Lab led by professors Brian Pogue and Keith Paulsen—with first author and PhD candidate David M. McClatchy III—devised a novel approach to help prevent cancerous tissue left behind due to unclear margins.
NSF Picks 16 for Graduate Research Fellowships
May 6, 2015 | Dartmouth Now
The winners include three Dartmouth engineers that were among the 2,000 selected from 16,500 applicants nationwide.
Jocelyn Shyong '16 was awarded The Bengt Sonnerup Fellowship for 2015–2016, part of the Energy Challenge Initiative to support research in the area of energy technologies.
Poster Session Features Graduate Students’ Research
April 20, 2015 | Dartmouth Now
Students presented their work to faculty members, peers, and others in the community.
Three Engineering Professors Selected for SYNERGY Translational Pilot Awards
April 17, 2015 | Dartmouth SYNERGY
The SYNERGY Translational Pilot Program facilitates collaborative translational research studies across Dartmouth and affiliated health centers and communities.
Beichen Dai '16 was awarded The Mazilu Engineering Research Fellowship for 2015–2016.
Dartmouth investigators led by Karl Griswold are engineering antibacterial enzymes to target the prevalent drug-resistant bacterium Staphylococcus aureus.
“Firefly” Mechanism Makes Cancer Studies More Efficient, Less Expensive
April 1, 2015 | NCCC
The mechanism that makes fireflies glow through a process called bioluminescence can be used to study tumor response to therapy as well.
Researchers Use Nanoparticles to Selectively Target Tumor Cells in Two Cancer Models
March 25, 2015 | NCCC
Professor Karl Griswold: "The ultimate utility of anti-cancer nanoparticle technologies will depend in large part on their capacity to selectively home to cancer cells."